September 2, 2016 / 3:22 PM / a year ago

BUZZ-Biotechs fall after Clinton plan to address 'unjustified' price hikes

** Biotech stocks down 1-3 pct after Democratic presidential nominee Hillary Clinton promises oversight panel to protect consumers from price hikes on life-saving drugs if elected

** Mylan down 2.3 pct, Celgene 0.5 pct, Bristol-Myers Squibb Co 1.7 percent, Mallinckrodt Plc 1.8 pct

** Clinton has been very critical about price gouging by drug companies; the Nasdaq biotech index is down about 5 pct through Thursday since she called on Mylan to lower price of Epipen on Aug. 24

** Biotechnology index currently up 0.43 pct, boosted largely by Biogen Inc after company’s experimental Alzheimer’s drug gets “fast-track” designation

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below